loadpatents
name:-0.017102956771851
name:-0.011191129684448
name:-0.0020949840545654
GARDINIER; Kevin Matthew Patent Filings

GARDINIER; Kevin Matthew

Patent Applications and Registrations

Patent applications and USPTO patent grants for GARDINIER; Kevin Matthew.The latest application filed is for "2-azaspiro[3.4]octane derivatives as m4 agonists".

Company Profile
1.10.14
  • GARDINIER; Kevin Matthew - Arlington MA
  • Gardinier; Kevin Matthew - Fishers IN
  • Gardinier; Kevin Matthew - Indianapolis IN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
2-azaspiro[3.4]octane Derivatives As M4 Agonists
App 20210130365 - CALHOUN; Amy ;   et al.
2021-05-06
2-azaspiro[3.4]octane Derivatives As M4 Agonists
App 20210107889 - CALHOUN; Amy ;   et al.
2021-04-15
6-substituted-3H-1,3-benzothiazol-2-one compounds as TARP-gamma 8 dependent AMPA receptor antagonists
Grant 9,469,632 - Gardinier , et al. October 18, 2
2016-10-18
6-substituted-3h-1,3-benzothiazol-2-one Compounds As Tarp-gamma 8 Dependent Ampa Receptor Antagonists
App 20150344468 - GARDINIER; Kevin Matthew ;   et al.
2015-12-03
Novel Mch Receptor Antagonists
App 20120302547 - Arnold; Macklin Brian ;   et al.
2012-11-29
MCH receptor antagonists
Grant 8,263,772 - Arnold , et al. September 11, 2
2012-09-11
MCH receptor antagonists
Grant 8,101,764 - Amegadzie , et al. January 24, 2
2012-01-24
5- [4-(azetidin-3-yloxy)-phenyl]-2-phenyl-5H-thiazolo[5,4-C] pyridin-4-one derivatives and their use as MCH receptor antagonists
Grant 8,049,013 - Gardinier , et al. November 1, 2
2011-11-01
Thiazolopyridinone derivates as MCH receptor antagonists
Grant 7,902,356 - Amegadzie , et al. March 8, 2
2011-03-08
MCH receptor antagonists
Grant 7,838,543 - Beck , et al. November 23, 2
2010-11-23
5- [4-(azetidin-3-yloxy)-phenyl]-2-phenyl-5h-thiazolo[5,4-c] Pyridin-4-one Derivatives And Their Use As Mch Receptor Antagonists
App 20100069352 - Gardinier; Kevin Matthew ;   et al.
2010-03-18
Novel Mch Receptor Antagonists
App 20100016350 - Amegadzie; Albert Kudzovi ;   et al.
2010-01-21
CB1 modulator compounds
Grant 7,595,339 - Allen , et al. September 29, 2
2009-09-29
Thiazolopyridinone Derivates As Mch Receptor Antagonists
App 20090233919 - Amegadzie; Albert Kudzovi ;   et al.
2009-09-17
Novel Mch Receptor Antagonists
App 20090170913 - Beck; James Peter ;   et al.
2009-07-02
Novel Mch Receptor Antagonists
App 20090093456 - Arnold; Macklin Brian ;   et al.
2009-04-09
Cb1 Modulator Compounds
App 20080287504 - Allen; Jennifer Rebecca ;   et al.
2008-11-20
Triazole derivatives as tachykinin receptor antagonists
Grant 7,320,994 - Amegadzie , et al. January 22, 2
2008-01-22
CB1 antagonist compounds
Grant 7,276,516 - Allen , et al. October 2, 2
2007-10-02
Cb1 antagonist compounds
App 20070088018 - Allen; Jennifer Rebecca ;   et al.
2007-04-19
Tachykinin receptor antagonists
Grant 7,179,804 - Amegadzie , et al. February 20, 2
2007-02-20
Tachykinin receptor antagonists
App 20060160794 - Amegadzie; Albert Kudzovi ;   et al.
2006-07-20
Tachykinin receptor antagonists
App 20050239776 - Amegadzie, Albert Kudzovi ;   et al.
2005-10-27
Triazole derivatives as tachykinin receptor antagonists
App 20050239786 - Amegadzie, Albert Kudzovi ;   et al.
2005-10-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed